Literature DB >> 3962188

Messenger RNA of the M segment RNA of Rift Valley fever virus.

M S Collett.   

Abstract

The putative messenger RNA (mRNA) of the M segment RNA of the phlebovirus Rift Valley fever virus (RVFV) has been characterized using S1 nuclease mapping and oligonucleotide primer extension procedures. These experiments revealed that the 3' end of the mRNA lacks approximately 112 nucleotides of the M genomic RNA sequences, and that the 5' end of the mRNA possesses all of the sequences present at the 3' end of the M RNA but is further extended beyond the end of the genome by some 12-14 nucleotides of unknown origin. The implications of these data are discussed in relation to the replication and expression strategy of this virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3962188     DOI: 10.1016/0042-6822(86)90114-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  In vivo analysis of the TSWV cap-snatching mechanism: single base complementarity and primer length requirements.

Authors:  D Duijsings; R Kormelink; R Goldbach
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection.

Authors:  Sonja R Gerrard; Brian H Bird; Cesar G Albariño; Stuart T Nichol
Journal:  Virology       Date:  2006-10-30       Impact factor: 3.616

3.  A shared transcription termination signal on negative and ambisense RNA genome segments of Rift Valley fever, sandfly fever Sicilian, and Toscana viruses.

Authors:  César G Albariño; Brian H Bird; Stuart T Nichol
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

4.  Host-derived 5' ends and overlapping complementary 3' ends of the two mRNAs transcribed from the ambisense S segment of Uukuniemi virus.

Authors:  J F Simons; R F Pettersson
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs.

Authors:  P Vialat; M Bouloy
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.

Authors:  Bonto Faburay; William Wilson; D Scott McVey; Barbara S Drolet; Hana Weingartl; Daniel Madden; Alan Young; Wenjun Ma; Juergen A Richt
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-20       Impact factor: 2.133

7.  Concurrent sequence analysis of 5' and 3' RNA termini by intramolecular circularization reveals 5' nontemplated bases and 3' terminal heterogeneity for lymphocytic choriomeningitis virus mRNAs.

Authors:  B J Meyer; P J Southern
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment.

Authors:  J A Suzich; L T Kakach; M S Collett
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

9.  Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.

Authors:  James F Papin; Paulo H Verardi; Leslie A Jones; Francisco Monge-Navarro; Aaron C Brault; Michael R Holbrook; Melissa N Worthy; Alexander N Freiberg; Tilahun D Yilma
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-23       Impact factor: 11.205

10.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.